← Back to Search
Newly Diagnosed Idiopathic Thrombocytopenic Purpura In Childhood: An Observational Study
T. Kühne, P. Imbach, P. Bolton-Maggs, W. Berchtold, V. Blanchette, G. Buchanan
Published 2001 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
BACKGROUND Diagnosis and management of idiopathic thrombocytopenic purpura (ITP) have been based primarily on expert opinion and practice guidelines rather than on evidence. We have used a registry to prospectively survey the presenting features and the diagnostic evaluation and management practices used for children with ITP worldwide. METHODS We used the Intercontinental Childhood ITP Registry which had been widely advertised. 209 physicians from 136 institutions in 38 countries participated by submitting data for each of their newly diagnosed patients. Data from 2031 children with ITP was registered between June, 1997, and May, 2000, and we analysed 6-month follow-up data from 1496 children. FINDINGS There was a peak in occurrence of childhood ITP during spring and a nadir in the autumn. Mean initial platelet count was 15.4x10(9)/L (SD 19.7). 1447 (73%) of 1976 children were admitted to hospital. Initial management consisted of no drug treatment in 612 (31%), intravenous immunoglobulin in 576 (29%), corticosteroids in 651 (33%), or both in 137 (7%) patients. Intracranial haemorrhage was reported in two patients. INTERPRETATION The variable approaches to management of childhood ITP demonstrate the need for prospective clinical trials, which should be feasible within such a study group.
This paper references
Idiopathic thrombocytopenic purpura in childhood.
J. Lusher (1966)
Letter: Splenectomy and lymphomas.
Stephens Rl (1975)
Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study.
J. Sartorius (1984)
Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura: A randomized clinical trial
G. Buchanan (1984)
INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD
P. Imbach (1985)
Treatment of acute idiopathic thrombocytopenic purpura.
V. Blanchette (1986)
Is bone marrow examination justified in idiopathic thrombocytopenic purpura?
D. Halpérin (1988)
Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study.
A. Dubansky (1989)
Idiopathic thrombocytopenic purpura: predictors of chronic disease.
L. Robb (1990)
Bone marrow examination before steroids in thrombocytopenic purpura or arthritis
M. Reid (1992)
Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.
O. Eden (1992)
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
V. Blanchette (1993)
Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.
J. Lilleyman (1994)
Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better?
S. Aronis (1994)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
J. George (1996)
Acute idiopathic thrombocytopenic purpura--management in childhood.
G. Buchanan (1997)
Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines
P. Bolton-Maggs (1997)
Is Bone Marrow Aspiration Needed in Acute Childhood Idiopathic Thrombocytopenic Purpura to Rule Out Leukemia
C. Calpin (1998)
Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
D. Medeiros (1998)
Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.
S. Jayabose (1999)
Management of childhood idiopathic thrombocytopenic purpura
J. Lilleyman (1999)
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.
S. Vesely (2000)
Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
A. Gaines (2000)
Ethnicity and Environment May Affect the Phenotype of Immune Thrombocytopenic Purpura in Children
T. Kühne (2000)
The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
R. Dickerhoff (2000)
This paper is referenced by
Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults
Ruqayyah J Almizraq (2021)
What are the new findings with regard to the mysterious disease idiopathic granulomatous mastitis?
H. Koksal (2021)
Retrospective Evaluation of Chronic Idiopathic Thrombocytopenia in Libyan Children
H. A. Elhashmi (2021)
Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia
B. Gruhn (2021)
Pediatric bleeding disorders
Yaser A Diab (2021)
ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
Hannah von Lukowicz (2021)
Immune Thrombocytopenia in Adolescents
A. Griffith (2020)
Pediatric Bleeding Disorders: A Clinical Casebook
A. Dunn (2020)
Trombocitopenia inmune primaria: experiencia de una consulta especializada
Carmen Rodríguez-Vigil Iturrate (2020)
Age at Diagnosis Shapes the Prognosis of Childhood Immune Thrombocytopenia
David E. Schmidt (2020)
Primary immune thrombocytopenia: Experience of a specialised clinic
Carmen Rodríguez-Vigil Iturrate (2020)
Seasonal variations in hematological disorders: A 10‐year single‐center experience
J. Hassan (2020)
Approach to a Patient with Sudden Onset of Mucocutaneous Bleeding and Thrombocytopenia
M. Rose (2020)
Clinical and laboratory factors affecting chronicity in children diagnosed with immune thrombocytopenia
Y. Ay (2020)
[Guideline for diagnosis and treatment of immune thrombocytopenia].
H. Donato (2019)
G537 A retrospective analysis of recurrent paediatric ependymoma: poor survival and ineffective therapy necessitates a better understanding of relapse biology to develop improved therapeutic approaches
T. Ritzmann (2019)
G539(P) Screening for depression among parents of patients with thalassemia using patient health questionnaire (phq-9)
S. Sen (2019)
Immune Thrombocytopenia Due to Mycoplasma pneumoniae Infection
Hakan Sarbay (2019)
Cytomegalovirus Has No Impact on Immune Thrombocytopenia Bleeding Scale or Prognostic Outcomes in Egyptian Pediatric Immune Thrombocytopenia
G. Mokhtar (2019)
Опыт лечения иммунной тромбоцитопении в отделении онкогематологии Воронежской областной детской клинической больницы № 1
Н. Б. Юдина (2019)
The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States
Jaime L. Shaw (2019)
The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
Jalil I Alezzi (2019)
Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
E. Monteagudo (2019)
Investigation of Dynamic Thiol/Disulfide Homeostasis in Children With Acute Immune Thrombocytopenia
H. Beyazit (2019)
Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria: PTI-2018
E. Monteagudo (2019)
Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals.
A. Balch (2019)
The impact of helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura
Sara Aljarad (2018)
Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia
S. Li (2018)
Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group
T. Kühne (2018)
Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population
J. Jaime-Pérez (2018)
Advances in chemical pharmacotherapy for the treatment of pediatric immune thrombocytopenia
T. Kühne (2018)
A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP
F. Rodeghiero (2018)See more